Serum IL-7 and G-CSF in major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 846-851

  Lehto, Soili M ^a   Huotari, Anne ^a,b   Niskanen, Leo ^a   Herzig, Karl Heinz ^a,b   Tolmunen, Tommi ^a   Viinamäki, Heimo ^a   Koivumaa Honkanen, Heli ^a,b,c   Honkalampi, Kirsi ^d   Sinikallio, Sanna ^e   Ruotsalainen, Heli ^b   Hintikka, Jukka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c LAPLAND CENTRAL HOSPITAL   (Finland)

^d Kuopio Psychiatric Center   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

G CSF; Growth factors; IL 7; Inflammation; Major depressive disorder

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 7; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENDER; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; SLEEP DISORDER; SMOKING; T LYMPHOCYTE; BLOOD; HOSPITALIZATION; MIDDLE AGED; NONPARAMETRIC TEST; PSYCHOLOGICAL RATING SCALE; RISK;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-7; MALE; MIDDLE AGED; ODDS RATIO; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 78049434900     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.03.033     Document Type: Article

References (51)

1. Almeida O.P., Norman P.E., Allcock R., Bockxmeer F.V., Hankey G.J., Jamrozik K., Flicker L. Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol 2009, 38:1049-1059.
2. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, DSM-IV, Washington, DC. 4th edn.
3. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004, 66:411-421.
4. Bagby R.M., Parker J.D.A., Taylor G.J. The twenty-item Toronto Alexithymia Scale-I: item selection and cross-validation of the factor structure. J Psychosom Res 1994, 38:23-32.
5. Bagby R.M., Taylor G.J., Parker J.D.A. The twenty-item Toronto Alexithymia Scale-II. Convergent, discriminant, and concurrent validity. J Psychosom Res 1994, 38:33-40.
6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
7. Benedict C., Dimitrov S., Marshall L., Born J. Sleep enhances serum interleukin-7 concentrations in humans. Brain Behav Immun 2007, 21:1058-1062.
8. Calzascia T., Pellegrini M., Lin A., Garza K.M., Elford A.R., Shahinian A., Ohashi P.S., Mak T.W. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc Natl Acad Sci U S A 2008, 105:2999-3004.
9. Chapman B.P., Khan A., Harper M., Stockman D., Fiscella K., Walton J., Duberstein P., Talbot N., Lyness J.M., Moynihan J. Gender, race/ethnicity, personality, and interleukin-6 in urban primary care patients. Brain Behav Immun 2009, 23:636-642.
10. Curtin N.M., Mills K.H., Connor T.J. Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide. Brain Behav Immun 2009, 23:371-379.
11. Dhabhar F.S., Burke H.M., Epel E.S., Mellon S.H., Rosser R., Reus V.I., Wolkowitz O.M. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res 2009, 43:962-969.
12. de Jager W., te Velthuis H., Prakken B.J., Kuis W., Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear. Cells Clin Diagn Lab Immunol 2003, 10:133-139.
13. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
14. Elshal M.F., McCoy J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006, 38:317-323.
15. Expert panel on detection, evaluation and treatment of high blood cholesterols in adults. Executive summary of the third Report of the National Cholesterol Education Program (NCEP).Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
16. Fry T.J., Mackall C.L. Interleukin-7: from bench to clinic. Blood 2002, 99:3892-3904.
17. Genser B., Cooper P.J., Yazdanbakhsh M., Barreto M.L., Rodrigues L.C. A guide to modern statistical analysis of immunological data. BMC Immunol 2007, 8:27.
18. Gimeno D., Kivimäki M., Brunner E.J., Elovainio M., De Vogli R., Steptoe A., Kumari M., Lowe G.D., Rumley A., Marmot M.G., Ferrie J.E. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2009, 39:413-423.
19. Gringhuis S.I., de Leij L.F., Verschuren E.W., Borger P., Vellenga E. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Blood 1997, 90:2690-2700.
20. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. American Heart Association; National Heart, Lung, and Blood Institute.
21. Himmerich H., Binder E.B., Künzel H.E., Schuld A., Lucae S., Uhr M., Pollmächer T., Holsboer F., Ising M. Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol Psychiatry 2006, 60:882-888.
22. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20years of progress and discovery. Brain Behav Immun 2007, 21:374-383.
23. Jiang Q., Li W.Q., Aiello F.B., Mazzucchelli R., Asefa B., Khaled A.R., Durum S.K. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005, 16:513-533.
24. Khairova R.A., Machado-Vieira R., Du J., Manji H.K. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 2009, 12:561-578.
25. Kim Y.K., Na K.S., Shin K.H., Jung H.Y., Choi S.H., Kim J.B. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1044-1053.
26. Kim H.R., Hwang K.A., Park S.H., Kang I. IL-7 and IL-15: biology and roles in T-cell immunity in health and disease. Crit Rev Immunol 2008, 28:325-339.
27. Kleinschnitz C., Schroeter M., Jander S., Stoll G. Induction of granulocyte colony-stimulating factor mRNA by focal cerebral ischemia and cortical spreading depression. Brain Res Mol Brain Res 2004, 131:73-78.
28. Koivumaa-Honkanen H.T., Honkanen R., Viinamäki H., Heikkilä K., Kaprio J., Koskenvuo M. Self-reported life satisfaction and 20-year mortality in healthy Finnish adults. Am J Epidemiol 2000, 152:983-991.
29. Lehto S.M., Niskanen L., Herzig K.-H., Tolmunen T., Huotari A., Viinamäki H., Koivumaa-Honkanen H., Honkalampi K., Ruotsalainen H., Hintikka J. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 2010, 35:226-232.
30. Lehto S.M., Huotari A., Niskanen L., Tolmunen T., Koivumaa-Honkanen H., Honkalampi K., Ruotsalainen H., Herzig K.-H., Viinamäki H., Hintikka J. Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatr Scand 2010, 121:209-215.
31. Leng S.X., McElhaney J.E., Walston J.D., Xie D., Fedarko N.S., Kuchel G.A. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 2008, 63:879-884.
32. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24:27-53.
33. Merikangas K.R., Zhang H., Avenevoli S., Acharyya S., Neuenschwander M., Angst J. Zurich Cohort Study. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry 2003, 60:993-1000.
34. Michaelson M.D., Mehler M.F., Xu H., Gross R.E., Kessler J.A. Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Dev Biol 1996, 179:251-263.
35. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
36. Miller A.H. Depression and immunity: a role for T cells?. Brain Behav Immun 2010, 24:1-8.
37. Myint A.M., Leonard B.E., Steinbusch H.W., Kim Y.K. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 2005, 88:167-173.
38. Pitsavos C., Panagiotakos D.B., Papageorgiou C., Tsetsekou E., Soldatos C., Stefanadis C. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis 2006, 185:320-326.
39. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
40. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:201-217.
41. Schneider A., Kuhn H.G., Schäbitz W.R. A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 2005, 4:1753-1757.
42. Schneider A., Krüger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., Schäbitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005, 115:2083-2098.
43. Simon N.M., McNamara K., Chow C.W., Maser R.S., Papakostas G.I., Pollack M.H., Nierenberg A.A., Fava M., Wong K.K. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol 2008, 18:230-233.
44. Smith R.S. The macrophage theory of depression. Med Hypotheses 1991, 35:298-306.
45. Stewart J.C., Rand K.L., Muldoon M.F., Kamarck T.W. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun 2009, 23:936-944.
46. Surh C.D., Boyman O., Purton J.F., Sprent J. Homeostasis of memory T cells. Immunol Rev 2006, 211:154-163.
47. Sutcigil L., Oktenli C., Musabak U., Bozkurt A., Cansever A., Uzun O., Sanisoglu S.Y., Yesilova Z., Ozmenler N., Ozsahin A., Sengul A. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007, 76396.
48. Viinamäki H., Heiskanen T., Lehto S.M., Niskanen L., Koivumaa-Honkanen H., Tolmunen T., Honkalampi K., Saharinen T., Haatainen K., Hintikka J. Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand 2009, 120:23-29.
49. Whooley M.A., Caska C.M., Hendrickson B.E., Rourke M.A., Ho J., Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry 2007, 62:314-320.
50. Williams J.B.W., Terman M. Structured interview guide for the Hamilton Depression Rating Scale with Atypical Depression Supplement (SIGH-ADS) 2003, New York State Psychiatric Institute, New York.
51. Zaharia M.D., Ravindran A.V., Griffiths J., Merali Z., Anisman H. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. J Affect Disord 2000, 58:1-10.